Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1989;20:1000-1004

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flegel, K. M.
Right arrow Articles by Hanley, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flegel, K. M.
Right arrow Articles by Hanley, J.

Stroke, Vol 20, 1000-1004, Copyright © 1989 by American Heart Association


ARTICLES

Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation

KM Flegel and J Hanley
Department of Medicine, McGill University, Montreal, Canada.

Factors associated with stroke and other cardiac embolic events in subjects with nonrheumatic atrial fibrillation were examined in a retrospective study of 91 patients from a teaching hospital clinic. There were 28 first strokes during 355 person-years of follow-up (7.9 per 100 person-years). Patients who had experienced one or more previous events were approximately 2.3 times more likely to have a subsequent event (hazard ratio 2.3, 95% confidence interval 1.5-3.4) than patients who had experienced no events. A univariate analysis of factors associated with a first stroke of any cause or other embolic event showed that age of greater than 75 years (hazard ratio 2.5) and systolic blood pressure of greater than 160 mm Hg (hazard ratio 6.4) were significant factors. After adjusting for the effect of age and systolic blood pressure, previous events still carried an increased risk for subsequent events. Subject with nonrheumatic atrial fibrillation who have had one or more embolic events are at high risk of further emboli. They require special consideration when treatment is being planned.


This article has been cited by other articles:


Home page
CirculationHome page
B. F. Gage, C. van Walraven, L. Pearce, R. G. Hart, P. J. Koudstaal, B.S.P. Boode, and P. Petersen
Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin
Circulation, October 19, 2004; 110(16): 2287 - 2292.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. F. Gage, A. D. Waterman, W. Shannon, M. Boechler, M. W. Rich, and M. J. Radford
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
JAMA, June 13, 2001; 285(22): 2864 - 2870.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. G. Hart and J. L. Halperin
Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
Ann Intern Med, November 2, 1999; 131(9): 688 - 695.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. R. Di Tullio, R. L. Sacco, R. R. Sciacca, and S. Homma
Left Atrial Size and the Risk of Ischemic Stroke in an Ethnically Mixed Population
Stroke, October 1, 1999; 30(10): 2019 - 2024.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. G. Hart, L. A. Pearce, R. McBride, R. M. Rothbart, and R. W. Asinger
Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation : Analysis of 2012 Participants in the SPAF I–III Clinical Trials
Stroke, June 1, 1999; 30(6): 1223 - 1229.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
V. Pengo, A. Zasso, F. Barbero, A. Biasiolo, P. Rampazzo, and T. Brocco
Initiation of Warfarin Treatment in Outpatients with Nonrheumatic Atrial Fibrillation: A Scheme for Early Indication of Maintenance Dose
Clinical and Applied Thrombosis/Hemostasis, October 1, 1998; 4(4): 274 - 276.
[Abstract] [PDF]


Home page
JAMAHome page
The SPAF III Writing Committee for the Stroke Prev
Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin: Stroke Prevention in Atrial Fibrillation III Study
JAMA, April 22, 1998; 279(16): 1273 - 1277.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. M Oppenheimer and J. Lima
Neurology and the heart
J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 289 - 297.
[Full Text] [PDF]


Home page
CirculationHome page
E. N. Prystowsky, D. W. Benson Jr, V. Fuster, R. G. Hart, G. N. Kay, R. J. Myerburg, G. V. Naccarelli, and D. G. Wyse
Management of Patients With Atrial Fibrillation : A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
Circulation, March 15, 1996; 93(6): 1262 - 1277.
[Full Text]


Home page
JAMAHome page
B. F. Gage, A. B. Cardinalli, G. W. Albers, and D. K. Owens
Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial Fibrillation
JAMA, December 20, 1995; 274(23): 1839 - 1845.
[Abstract] [PDF]


Home page
StrokeHome page
H.-J. Lin, P. A. Wolf, E. J. Benjamin, A. J. Belanger, and R. B. D'Agostino
Newly Diagnosed Atrial Fibrillation and Acute Stroke : The Framingham Study
Stroke, September 1, 1995; 26(9): 1527 - 1530.
[Abstract] [Full Text]


Home page
BMJHome page
C M Sudlow, H Rodgers, R A Kenny, and R G Thomson
How To Do It: Service provision and use of anticoagulants in atrial fibrillation
BMJ, August 26, 1995; 311(7004): 558 - 560.
[Full Text]


Home page
CirculationHome page
E. J. Benjamin, R. B. D'Agostino, A. J. Belanger, P. A. Wolf, and D. Levy
Left Atrial Size and the Risk of Stroke and Death : The Framingham Heart Study
Circulation, August 15, 1995; 92(4): 835 - 841.
[Abstract] [Full Text]


Home page
StrokeHome page
J.C. van Latum, P.J. Koudstaal, G.S. Venables, J. van Gijn, L.J. Kappelle, and A. Algra
Predictors of Major Vascular Events in Patients With a Transient Ischemic Attack or Minor Ischemic Stroke and With Nonrheumatic Atrial Fibrillation
Stroke, May 1, 1995; 26(5): 801 - 806.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
D. C. McCrory, D. B. Matchar, G. Samsa, L. L. Sanders, and E. L. C. Pritchett
Physician Attitudes About Anticoagulation for Nonvalvular Atrial Fibrillation in the Elderly
Arch Intern Med, February 13, 1995; 155(3): 277 - 281.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
L. K. Gottlieb and S. Salem-Schatz
Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice?
Arch Intern Med, September 12, 1994; 154(17): 1945 - 1953.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
The Stroke Prevention in Atrial Fibrillation Inves
Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk
Ann Intern Med, January 1, 1992; 116(1): 1 - 5.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
The Stroke Prevention in Atrial Fibrillation Inves
Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at Risk
Ann Intern Med, January 1, 1992; 116(1): 6 - 12.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
G. W. Albers, J. E. Atwood, J. Hirsh, D. G. Sherman, R. A. Hughes, and S. J. Connolly
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Intern Med, November 1, 1991; 115(9): 727 - 736.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
P. Petersen, J. Kastrup, S. Helweg-Larsen, G. Boysen, and J. Godtfredsen
Risk Factors for Thromboembolic Complications in Chronic Atrial Fibrillation: The Copenhagen AFASAK Study
Arch Intern Med, April 1, 1990; 150(4): 819 - 821.
[Abstract] [PDF]